A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
Real Madrid vs Atletico Madrid Showdown: What to Expect and How to Watch
Ipswich vs Everton: Can Everton Maintain Their Upward Momentum Amidst Injuries?
Elisabeth Finch's Fabricated Cancer Diagnosis: Apology and Docuseries Reveal Depth of Deceit
Veteran Filmmaker Rakesh Roshan Retires from Directing, Teases 'Krrish 4' Updates
Kylian Mbappé Channels Cristiano Ronaldo with Passionate '1, 2, 3... Hala Madrid!' Tribute
